# ESTRADIOL AND NORETHINDRONE ACETATE
> **ANDA210233** · Abbreviated New Drug Application (Generic) · Sponsor: NAARI PTE · Approved 2018-02-28
## Drug
- **FDA Application Number:** ANDA210233
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ESTRADIOL AND NORETHINDRONE ACETATE
- **Generic name:** ESTRADIOL AND NORETHINDRONE ACETATE
- **Active ingredients:** ESTRADIOL; NORETHINDRONE ACETATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NAARI PTE
- **Manufacturer:** Naari Pte. Limited
- **First approval:** 2018-02-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210233)
---
*MORVS · CC0 1.0*